Sanofi Q2 2013 - Interview With CEO Chris Viehbacher

Sanofi, a global and diversified healthcare leader, reports results for the second quarter of 2013. CEO Chris Viehbacher comments on Q2 results and outlook.

Watch the video interview here:

http://www.eurobusinessmedia.com/Sanofi-Q2-2013-Interview-with-CEO-Chris-Viehbacher?utm_source=ceo-direct&utm_medium=bw

Topics covered in the interview include:

- Q2 2013 Results

- FY 2013 Guidance

- Capital Allocation

- Diabetes

- Vaccines

- Genzyme

- Animal Health

- Emerging Markets

- R&D Pipeline

- Recent appointments

About Sanofi

Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Company website: www.sanofi.com

Copyright Business Wire 2010

If you liked this article you might like

Dominion Energy, U.S. Concrete, AMD: 'Mad Money' Lightning Round

Dominion Energy, U.S. Concrete, AMD: 'Mad Money' Lightning Round

The Ups and Downs of This Market: Cramer's 'Mad Money' Recap (Wednesday 1/24/18)

The Ups and Downs of This Market: Cramer's 'Mad Money' Recap (Wednesday 1/24/18)

Ripple's Recent Partnerships Fuel Crypto's Massive Spike

Ripple's Recent Partnerships Fuel Crypto's Massive Spike

Walmart Closes Dozens of Sam's Clubs, Some Without Warning: LIVE MARKETS BLOG

Walmart Closes Dozens of Sam's Clubs, Some Without Warning: LIVE MARKETS BLOG

5 Top Bank Stocks in Europe to Own, According to Strategists

5 Top Bank Stocks in Europe to Own, According to Strategists